|
CHMP4C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.747000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.836820E-01 |
| Normal-vs-Stage2 |
3.979000E-01 |
| Normal-vs-Stage3 |
6.580200E-01 |
| Normal-vs-Stage4 |
5.962600E-01 |
| Stage1-vs-Stage2 |
2.228500E-02 |
| Stage1-vs-Stage3 |
2.417600E-01 |
| Stage1-vs-Stage4 |
4.828200E-01 |
| Stage2-vs-Stage3 |
1.499840E-01 |
| Stage2-vs-Stage4 |
1.674580E-01 |
| Stage3-vs-Stage4 |
8.588000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.610200E-01 |
| Normal-vs-AfricanAmerican |
1.517370E-01 |
| Normal-vs-Asian |
5.356000E-02 |
| Caucasian-vs-AfricanAmerican |
2.773800E-01 |
| Caucasian-vs-Asian |
5.634400E-02 |
| AfricanAmerican-vs-Asian |
7.532400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.018600E-01 |
| Normal-vs-Female |
2.542200E-01 |
| Male-vs-Female |
1.568180E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.913600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.120400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.264000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.874600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.253700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.923500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.504020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.523800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.998000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.319000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.182200E-01 |
| Classical-VS-Follicular |
5.66049999999318E-05 |
| Classical-VS-Other |
4.238200E-01 |
| Classical-VS-Normal |
9.516300E-02 |
| Tall-VS-Follicular |
6.361900E-03 |
| Tall-VS-Other |
6.723200E-01 |
| Tall-VS-Normal |
1.030380E-01 |
| Follicular-VS-Other |
6.397700E-02 |
| Follicular-VS-Normal |
1.915760E-01 |
| Other-VS-Normal |
1.866050E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.828200E-01 |
| Normal-vs-N1 |
3.863400E-01 |
| N0-vs-N1 |
3.280400E-01 |
|
|
